Wytwarzanie produktów leczniczych jest dla nas nie tylko kwestia wykonania pewnego procesu technologicznego, ale misją związaną z człowiekiem opartą na wysokim standardzie jakości, bezpieczeństwa i skuteczności leków.
Mamy aktywną i kluczową rolę w podnoszeniu standardów życia codziennego. Sprawiamy, że społeczeństwo jest lepiej poinformowane, zdrowsze, szczęśliwsze i bezpieczniejsze
SOPHARMA AD hereby informs that from 09 July 2015 up to and including 15 July 2015 the Company bought 500 own shares representing 0.00037% of the share capital of the Company, at a total value of 1444.00 BGN on the Bulgarian Stock Exchange, the average price per share was 2.888 BGN.
The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
The total number of treasury shares after these transactions is 5 169 832, representing 3.84% of the share capital of the Company.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs of the results of the tender offering for the shares of Momina Krepost AD, published in two national newspapers: Capital Daily and Sega on 1 July 2015.
In connection with the requirements of art. 37, par. 1 of Ordinance №13 for tender offers for the purchase and exchange of shares, Sopharma AD as a tender offeror, who has made a tender offering under art. 149, par. 6 of POSA to purchase all shares of other shareholders of Momina Krepost AD, informs on the following results of the tender offering:
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 8 November 2012 up to and including 14 November 2012 the Company bought 56111 own shares representing 0.043% of the share capital of the Company, to the total value of BGN 127209.75 on the Bulgarian Stock Exchange. The average price per share was BGN 2.27.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
Sopharma AD notifies that for June 2015 the Company recorded a decrease of sales revenues of 36% compared to the same month of 2014, including same level of domestic sales and 51% decrease of export sales.
For the six months of this year, revenues from sales decreased by 16% compared to the same period of 2014, including 13% increase of domestic sales and a 28% decrease of export sales.
Pursuant to art. 157 of the POSA and art. 37 par. 1 of Ordinance №13 for tender offers for the purchase and exchange of shares, Sopharma AD as a tender offeror, who has made a tender offer under art. 149, par. 6 of POSA to purchase all the shares of the other shareholders of Momina Krepost AD informs on the following results of the tender offer: shareholders who have accepted the tender offer: 38 shareholders with a total number of shares: 211 991.
Pursuant to art. 117, par. 2 of the Public Offering of Securities Act and art. 27, par. 5 of Ordinance № 2/17.09.2003 on the prospectuses for public offerings of securities and disclosure of information by public companies and other issuers of securities, please be informed that the Extraordinary General Meeting of shareholders of Sopharma AD, held on 01.11.2012 in Sofia, 16 Iliensko shousee, took the following decision:
The Board of Directors of Sopharma AD (the “Company”) notifies that for October 2012 Sopharma AD realized decrease of sales revenues of 2% compared to the same period of 2011, including 10% decrease of domestic sales and 2% increase of export sales.
During the first ten months of this year Sopharma AD realized an increase of sales revenues of 2%, including 10% decrease of domestic sales and 7% increase of export sales compared to the same period of 2011.
Sopharma AD (the “Company”) announces that on 16 July 2015 the Company bought 240 000 shares from the capital of Medika AD. After this transaction, the share of Sopharma AD in the capital of Medika AD increased to 36.10%.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 25 October 2012 up to and including 31 October 2012 the Company bought 162303 own shares representing 0.123% of the share capital of the Company, to the total value of BGN 382683.79 on the Bulgarian Stock Exchange. The average price per share was BGN 2.36.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
Sopharma AD (the “Company”) hereby notifies that on 3 August 2015 Sopharma AD received a notification of disclosure of shareholdings from Telekomplekt invest AD regarding the purchasing of 108 700 shares. After this transaction the share of Telekomplekt invest AD in the capital of Sopharma AD reached 20.07%. The date of registration of the transaction with the Central Depository AD is 31 July 2015.